Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00843037
Title Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

paraganglioma

adrenal medulla cancer

Therapies

Sunitinib

Age Groups: adult
Covered Countries CAN


No variant requirements are available.